OTC Markets EXMKT - Delayed Quote USD
Nanobac Pharmaceuticals, Incorporated (NNBP)
0.0001
0.0000
(0.00%)
At close: April 23 at 4:00:00 PM EDT
Breakdown
TTM
Total Revenue
17.6210
Cost of Revenue
14.5190
Gross Profit
3.1020
Operating Expense
4,917.9130
Operating Income
-4,914.8110
Other Income Expense
-1,474.3960
Pretax Income
-6,576.1110
Net Income Common Stockholders
-6,576.1110
Diluted NI Available to Com Stockholders
-6,576.1110
Basic EPS
-0.03
Diluted EPS
-0.03
Basic Average Shares
245,197.5350
Diluted Average Shares
245,197.5350
Total Operating Income as Reported
4,914.8110
Total Expenses
4,932.4320
Net Income from Continuing & Discontinued Operation
-6,576.1110
Normalized Income
-5,101.7150
EBIT
-4,914.8110
EBITDA
-4,454.5090
Reconciled Cost of Revenue
14.5190
Reconciled Depreciation
460.3020
Net Income from Continuing Operation Net Minority Interest
-6,576.1110
Total Unusual Items Excluding Goodwill
-1,474.3960
Total Unusual Items
-1,474.3960
Normalized EBITDA
-2,980.1130
10/14/57281 - 10/31/1994
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade